Simran S. Sabharwal

2.0k total citations · 1 hit paper
8 papers, 1.6k citations indexed

About

Simran S. Sabharwal is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Simran S. Sabharwal has authored 8 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Simran S. Sabharwal's work include Cancer Immunotherapy and Biomarkers (3 papers), Mitochondrial Function and Pathology (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Simran S. Sabharwal is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Mitochondrial Function and Pathology (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Simran S. Sabharwal collaborates with scholars based in United States and Netherlands. Simran S. Sabharwal's co-authors include Paul T. Schumacker, Gregory B. Waypa, Jeremy D. Marks, Stephen J. Kron, Sergey A. Kozmin, Masato Suzuki, Olesya A. Ulanovskaya, Jelena M. Janjic, Mujahid A. Rizvi and Joan Guitart and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature reviews. Cancer and Biochemical Journal.

In The Last Decade

Simran S. Sabharwal

7 papers receiving 1.5k citations

Hit Papers

Mitochondrial ROS in cancer: initiators, amplifiers or an... 2014 2026 2018 2022 2014 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simran S. Sabharwal United States 5 930 397 212 197 157 8 1.6k
Darren R. Williams South Korea 27 1.4k 1.5× 396 1.0× 198 0.9× 302 1.5× 262 1.7× 80 2.4k
Bryce Wei Quan Tan Singapore 9 843 0.9× 267 0.7× 246 1.2× 253 1.3× 143 0.9× 12 1.7k
Rama Rao Malla India 18 750 0.8× 258 0.6× 194 0.9× 224 1.1× 192 1.2× 65 1.4k
Tingting Yang China 24 618 0.7× 281 0.7× 143 0.7× 182 0.9× 148 0.9× 70 1.4k
Amit Deorukhkar United States 18 953 1.0× 349 0.9× 339 1.6× 263 1.3× 89 0.6× 34 1.8k
Anand Krishnan V. Iyer United States 25 824 0.9× 257 0.6× 103 0.5× 207 1.1× 127 0.8× 50 1.5k
Antonio Pezone Italy 15 1.2k 1.3× 371 0.9× 368 1.7× 280 1.4× 206 1.3× 30 2.3k
Varisa Pongrakhananon Thailand 27 1.0k 1.1× 365 0.9× 115 0.5× 297 1.5× 85 0.5× 73 1.9k
Philip J. Moos United States 27 1.0k 1.1× 272 0.7× 132 0.6× 367 1.9× 142 0.9× 67 2.0k

Countries citing papers authored by Simran S. Sabharwal

Since Specialization
Citations

This map shows the geographic impact of Simran S. Sabharwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simran S. Sabharwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simran S. Sabharwal more than expected).

Fields of papers citing papers by Simran S. Sabharwal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simran S. Sabharwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simran S. Sabharwal. The network helps show where Simran S. Sabharwal may publish in the future.

Co-authorship network of co-authors of Simran S. Sabharwal

This figure shows the co-authorship network connecting the top 25 collaborators of Simran S. Sabharwal. A scholar is included among the top collaborators of Simran S. Sabharwal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simran S. Sabharwal. Simran S. Sabharwal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
3.
Sabharwal, Simran S., David B. Rosen, Jeff Grein, et al.. (2018). GITR Agonism Enhances Cellular Metabolism to Support CD8+ T-cell Proliferation and Effector Cytokine Production in a Mouse Tumor Model. Cancer Immunology Research. 6(10). 1199–1211. 44 indexed citations
4.
Sabharwal, Simran S., et al.. (2018). Ransomware Attack : India issues Red Alert. International Journal of Engineering Research and. V7(2). 1 indexed citations
5.
Sabharwal, Simran S. & Paul T. Schumacker. (2014). Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?. Nature reviews. Cancer. 14(11). 709–721. 1284 indexed citations breakdown →
6.
Sabharwal, Simran S., Gregory B. Waypa, Jeremy D. Marks, & Paul T. Schumacker. (2013). Peroxiredoxin-5 targeted to the mitochondrial intermembrane space attenuates hypoxia-induced reactive oxygen species signalling. Biochemical Journal. 456(3). 337–346. 55 indexed citations
7.
Ulanovskaya, Olesya A., Jelena M. Janjic, Masato Suzuki, et al.. (2008). Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide. Nature Chemical Biology. 4(7). 418–424. 82 indexed citations
8.
Querfeld, Christiane, Mujahid A. Rizvi, Timothy M. Kuzel, et al.. (2006). The Selective Protein Kinase C β Inhibitor Enzastaurin Induces Apoptosis in Cutaneous T-Cell Lymphoma Cell Lines through the AKT Pathway. Journal of Investigative Dermatology. 126(7). 1641–1647. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026